Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.
The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.
A single-child case report documents group A streptococcal toxic shock syndrome with acute necrotizing tracheobronchitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results